Not Hemo mice, but we are doing similar3 Oct 2020 14:50
Current landscape for COVID-19 neutralising antibodies
Neutralising antibody treatment is seen as a promising form of therapy for
COVID-19 and there are a number of groups, alongside Hemogenyx, looking to
develop treatments. Regeneron Pharmaceuticals is using its own mouse model
system, VelocImmune®, to isolate virus-neutralising antibodies.